Evidence map›Paper›PMID 24501251›Full record

ArticleRNA (New York, N.Y.)2014

Rat1p maintains RNA polymerase II CTD phosphorylation balance.

Silvia Jimeno-González, Manfred Schmid, Francisco Malagon, Line Lindegaard Haaning, Torben Heick Jensen

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Silvia Jimeno-González
Manfred Schmid
Francisco Malagon
Line Lindegaard Haaning
Torben Heick Jensen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In S. cerevisiae, the 5'-3' exonuclease Rat1p partakes in transcription termination. Although Rat1p-mediated RNA degradation has been suggested to play a role for this activity, the exact mechanisms by which Rat1p helps release RNA polymerase II (RNAPII) from the DNA template are poorly understood. Here we describe a function of Rat1p in regulating phosphorylation levels of the C-terminal domain (CTD) of the largest RNAPII subunit, Rpb1p, during transcription elongation. The rat1-1 mutant exhibits highly elevated levels of CTD phosphorylation as well as RNAPII distribution and transcription termination defects. These phenotypes are all rescued by overexpression of the CTD phosphatase Fcp1p, suggesting a functional relationship between the absence of Rat1p activity, elevated CTD phosphorylation, and transcription defects. We also demonstrate that rat1-1 cells display increased RNAPII transcription kinetics, a feature that may contribute to the cellular phenotypes of the mutant. Consistently, the rat1-1 allele is synthetic lethal with the rpb1-E1103G mutation, causing increased RNAPII speed, and is suppressed by the rpb2-10 mutation, causing slowed transcription. Thus, Rat1p plays more complex roles in controlling transcription than previously thought.

Indexed as

Blotting, WesternChromatinChromatin ImmunoprecipitationExoribonucleasesPhenotypePhosphoprotein PhosphatasesPhosphorylationProtein KinasesProtein Structure, TertiaryRNA Polymerase IISaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSerineTranscription, Geneticcarboxy-terminal domain phosphataseChromatinCTDK-I protein complex, S cerevisiaeExoribonucleasesPhosphoprotein PhosphatasesProtein KinasesRAT1 protein, S cerevisiaeRNA Polymerase IISaccharomyces cerevisiae ProteinsSerineCTD phosphorylationRNA polymerase IItranscription elongationtranscription termination

Identifiers

PMID24501251
PMCPMC3964916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.